| Autor: |
Laila A. Ahmed, Hayam H. Mansour, Salwa I. Elshennawy, Marwa A.A. Ramadan, Mohamed A.M. Kamal, Soso S. Mohamed, Omaima Mohamed Ali, Amal H. Ibrhim |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Infection Prevention in Practice, Vol 6, Iss 1, Pp 100338- (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2590-0889 |
| DOI: |
10.1016/j.infpip.2024.100338 |
| Popis: |
Summary: Background and aim: Patients with chronic kidney disease including those undergoing hemodialysis (HD) constitute a particularly challenging group regarding COVID-19 vaccination. The present study aimed to compare the rate of reinfection after two and three doses of Sinopharm COVID-19 vaccine in HD patients. Patients and methods: The study included 80 HD patients who received three doses of Sinopharm COVID-19 vaccine. In addition, there were another 80 patients who received only two doses of the vaccine. Patients in the latter group were selected based on propensity matching score with 1:1 ratio. Patients were monitored for post-vaccination COVID-19 infection using PCR examination of nasopharyngeal swabs. Patients were also monitored for post-vaccination complications including general complaints (headache, fever, fatigue), injection site complaints (arm pain, swelling, itching, rash), musculoskeletal complaints (muscle spasm or pain, joint pain) and others. All patients were followed for six months. Results: The present study included 80 patients submitted to COVID-19 vaccination with two doses of Sinopharm vaccine (GI) and other 80 patients who received three doses of the same vaccine (GII). At the end of follow up, 11 patients (13.8 %) in GI caught COVID-19 infection. In contrast, no patient in GII had infection (P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
